Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC35F4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
B3GALT5-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
AGBL4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRELP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FGD5-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRB3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GDPD5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
B4GALNT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRIN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC28B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABCC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OCM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MEGF6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DGKG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HFE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FXYD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
S1PR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRC4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on